Oxford and AstraZeneca agreed to supply the vaccine for US$2-$3 per dose to consumers. The vaccine consists of a coronavirus protein encoding DNA that is shuttled into cells in a harmless virus...
Oxford/AstraZeneca COVID-19 Vaccine Study Illustrates Remaining Uncertainty
